Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$39.33 USD
+0.90 (2.34%)
Updated Jul 31, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Biohaven Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 463 | 64 | 0 |
Cost Of Goods | 0 | 0 | 92 | 18 | 0 |
Gross Profit | 0 | 0 | 371 | 46 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 436 | 568 | 1,075 | 691 | 479 |
Income After Depreciation & Amortization | -436 | -568 | -704 | -645 | -479 |
Non-Operating Income | 27 | -2 | -5 | -28 | -10 |
Interest Expense | 0 | 0 | 134 | 86 | 39 |
Pretax Income | -410 | -570 | -843 | -758 | -528 |
Income Taxes | -1 | 0 | 5 | 10 | 0 |
Minority Interest | 0 | 0 | -2 | -2 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -408 | -570 | -848 | -769 | -529 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -408 | -570 | -847 | -767 | -529 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -429 | -567 | -679 | -631 | -473 |
Depreciation & Amortization (Cash Flow) | 7 | 1 | 25 | 14 | 6 |
Income After Depreciation & Amortization | -436 | -568 | -704 | -645 | -479 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 71.20 | 44.74 | 64.68 | 58.73 | 48.49 |
Diluted EPS Before Non-Recurring Items | -5.73 | -12.75 | -13.09 | -13.06 | -10.91 |
Diluted Net EPS (GAAP) | -5.73 | -12.75 | -13.09 | -13.06 | -10.91 |
Fiscal Year end for Biohaven Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 183.24 | 153.71 | 110.55 | 94.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -183.24 | -153.71 | -110.55 | -94.01 |
Non-Operating Income | NA | 4.31 | 7.74 | 4.69 | 5.84 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -178.94 | -145.97 | -105.86 | -88.17 |
Income Taxes | NA | 0.57 | -1.21 | -3.29 | 2.18 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -179.50 | -144.76 | -102.57 | -90.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -179.50 | -144.76 | -102.57 | -90.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 81.60 | 79.93 | 68.32 | 68.25 |
Diluted EPS Before Non-Recurring Items | NA | -2.20 | -1.81 | -1.50 | -1.32 |
Diluted Net EPS (GAAP) | NA | -2.20 | -1.88 | -1.50 | -1.32 |